Pharvaris N.V.
PHVS
$28.41
$4.2917.77%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -180.86M | -183.29M | -163.68M | -145.33M | -143.53M |
| Total Depreciation and Amortization | 447.60K | 372.60K | 329.60K | 290.80K | 264.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.23M | 30.71M | 17.14M | 8.83M | 21.45M |
| Change in Net Operating Assets | 7.55M | 3.87M | 2.10M | 6.28M | 3.51M |
| Cash from Operations | -147.63M | -148.34M | -144.11M | -129.93M | -118.30M |
| Capital Expenditure | -343.90K | -658.80K | -720.90K | -584.80K | -443.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -343.90K | -658.80K | -720.90K | -584.80K | -443.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -179.30K | -180.20K | -210.40K | -159.70K | -187.80K |
| Issuance of Common Stock | 171.99M | 1.64M | 2.08M | 2.24M | 280.36M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.91M | -1.00K | -67.10K | 591.90K | -16.33M |
| Cash from Financing | 188.06M | 1.59M | 1.96M | 2.91M | 284.08M |
| Foreign Exchange rate Adjustments | -2.98M | -9.32M | 1.39M | 7.83M | -8.33M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.12M | -156.73M | -141.48M | -119.78M | 157.00M |